Rates of change in FEV1 and DLCO as potential indicators for mTOR inhibitor therapy in premenopausal lymphangioleiomyomatosis patients - Taveira-DaSilva, A M; Julien-Williams, P; Jones, A M (Eur Respir J, 2018)
et al.